T5020
|
|
|
Others
|
Eptifibatide 是一种糖蛋白 IIb/IIIa 抑制剂类的抗血小板药物,是一种由 6 个氨基酸和一个巯基丙酰基残基构成的环状七肽。 |
T5146
|
|
|
Others
|
Eptifibatide acetate (148031-34-9 free base) 是一种糖蛋白 IIb/IIIa 抑制剂类的抗血小板药物,是一种由 6 个氨基酸和一个巯基丙酰基残基构成的环状七肽。 |
T71907
|
|
|
|
Eptifibatide is a potent glycoprotein IIb/IIIa antagonist (GPIIb/IIIa; Kd = 120 nM) that inhibits platelet aggregation. Eptifibatide prevents binding of the adhesion proteins fibrinogen and von Willebrand factor to GPIIb/IIIa on the surface of activated platelets to prevent aggregation and thrombus formation. It inhibits ADP-induced citrated blood aggregation (IC50 = 0.11-0.22 μg/ml) in vitro and in vivo (IC50 = 52 μg/ml in porcine plasma). Formulations containing eptifibatide have been used to reduce risk of thrombolysis in myocardial infarction in patients undergoing percutaneous coronary intervention. |
T75242
|
|
|
|
Bivalirudin TFA 是20个氨基多肽,可逆地抑制凝血酶。 |